Photo: 0AE.Deiters-Keul UKM Fotozentra
Dr. Dr. Sebastian Balbach’s research focuses on novel targeted therapies against cancer stem cells. These are the cells that fuel cancer growth and lead to relapse. For many common cancer types, research has identified cancer stem cells, and major advances in the development of therapies that target these stem cells have been made.
Dr. Dr. Balbach attempts to solve a long-standing but urgent question with novel methods: Are sarcomas, aggressive cancers of muscle, bone, or joints prevalent in children, driven by malignant stem cells? Conventional methods have failed to identify these stem cells. Sebastian Balbach will use novel single-cell sequencing technologies to find them, label them with molecular barcodes to track their fate, and identify their Achilles’ heels that can be targeted for future therapies. His vision is to eliminate cancer stem cells in sarcoma to truly cure this disease.
The project of Sebastian Balbach is supported by the “Young Investigator Fund for Innovative Research Ideas” of the Schering Stiftung and the Fritz Thyssen Foundation.Share this post
Dr. Dr. Sebastian Balbach studied Chemistry and Medicine at the Westphalian Wilhelms University Münster, and did his PhD and MD theses at the Max Planck Institute for Molecular Biomedicine in the lab of Prof. Hans Schöler. With a postdoctoral fellowship of the German Cancer Aid, he joined the lab of Prof. Stuart Orkin at the Harvard Medical School, Boston, U.S.A. Now he is a resident physician at the Department of Pediatric Hematology and Oncology, headed by Prof. Claudia Rössig, and leads a research project to find new treatments for children with cancer.
Unter den Linden 32-34
Telefon: +49 - 30 - 20 62 29 65
Thursday to Monday: 1 pm - 7 pm